Proscia: Choosing the Right Digital Pathology Platform: 7 Criteria for a Better Experience with Your AI Applications
recent articles
From Diagnostics World: By Deborah Borfitz March 7, 2024 | Biomedical engineers have a significant role to play in the development and optimization of liquid biopsies to further precision oncology. Although molecular...
CND Biomarker Testing Services Utilizing Groundbreaking NerValence™ System Unveiled at the AD/PD™ 2024 Parkinson's and Alzheimer's Disease Conference SCOTTSDALE, Ariz.., March 5, 2024 /PRNewswire/ -- CND Life Sciences (CND), a...
PathPresenter and Ibex Partner to Advance Digital Pathology and AI Solutions BOSTON and MONTVILLE, N.J., March 6, 2024 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, and PathPresenter, the...
Many, many thanks to Dr. Aleksandra Zuraw at the Digital Pathology Place for interviewing me recently and putting together this video and podcast. Her site is excellent with many interviews of key opinion leaders, thought leaders and digital...
Nijmegen, Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, announced the introduction of its NephroPath platform. By partnering with Aiosyn,...
Owkin selects Amazon Web Services (AWS) as its primary cloud provider to develop generative AI applications and accelerate drug discovery and development The company will leverage AWS’s scalable storage options, enhanced data security...
